Pacific Dermaesthetics
Vancouver, British Columbia, V6E 4M3, Canada
NCT Number: NCT02939105
Evaluate the safety and efficacy of the ZELTIQ CoolSculpting System using specialized vacuum applicators for non-invasive subcutaneous fat reduction of the upper arms.
Looking for future studies?
Notify Me22 year–65 year
All sexes
Interventional
Not applicable
Vancouver, British Columbia, V6E 4M3, Canada
Subcutaneous fat reduction of the upper arms using 2 vacuum applicator types will be done concurrently, such that a subject will have an applicator placed on each arm simultaneously.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The CoolSculpting device will be used to perform treatments.
Time frame: 12 weeks post-final treatment
Change in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images. Reviewers are practicing dermatologists or plastic surgeons. All reviewers will be blinded to post-treatment vs. baseline untreated area. The order in which images are presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair of subject images. Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form. Criteria for evaluable photos for the purposes of the independent review: subject completed treatment regimen; subject has complete set of baseline photos; subject has a complete set of post-treatment photos; photos were taken using Zeltiq standard procedure. The expected success rate is 70% correct identification by 2 out of 3 reviewers.
Time frame: Enrollment through12 weeks post-final treatment
The primary safety endpoint of the study is the incidence of unanticipated adverse device effects (UADE) reported in the study period. Investigators assessed each adverse event to determine if there was relationship to the study device or procedure. Adverse event data are collected from the time of study enrollment through the final follow-up visit at 12 weeks post-treatment.
Zeltiq Aesthetics
Industry
DualSculpting the Upper Arms Using Vacuum Applicators and a Customized Treatment Approach
Acronym: ARM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01859091
Body Fat Disorder
Pleasanton, California, United States
View Trial DetailsNCT03352141
Body Fat Disorder
Vancouver, British Columbia, Canada
View Trial DetailsNCT02081209
Body Fat Disorder
Marina del Rey, California, United States
View Trial DetailsNCT03738891
Body Fat Disorder
Marina del Rey, California, United States
View Trial Details